Impact of arthritis medications on the mother and child during pregnancy and beyond
FAMILY-Study_PLS-image

Scientific Study Title:

Following maternal, neonatal, and childhood outcomes associated with use of arthritis medications perinatally (FAMILY)

Start Date: 

End Date:

Mary De Vera
MSc, PhD, Associate Director of Training, Senior Scientist, Pharmacoepidemiology

Ready to Participate?

Life-changing arthritis research is only possible with your help!

Why do this research?

Reason For Research

Different types of arthritis strike people during their childbearing years. We have some information about the effects of arthritis medications on the baby, however, less data exists on the impacts later in childhood and on the person with arthritis who gave birth. We know even less about ways that newer drugs, such as biosimilars are being used during pregnancy and their impacts on the mother and child after giving birth.

Methodology

Execution of Research

State-of-the-art statistical methods will use “big data” to analyze British Columbia healthcare records of those women who are pregnant and have arthritis. The use of arthritis medications during pregnancy will be correlated to the health of birthing parents and their children. This will inform future treatment decisions for women with arthritis in their childbearing years.

Who is involved?

Involvement

This study will be completed using Administrative Health Data.

The project will use data that is already collected so there is no participant recruitment.

Related Research